Contact
 

AVAC: Global Advocacy for HIV Prevention is seeking feedback to better understand how their materials and website are used and how they can be improved. AVAC asks advocates to complete the AVAC...

The theme of the forum is Strengthening Research Partnerships for Better Health and Sustainable Development, taking into account the past, present and future of EDCTP. For more information,...

UNAIDS’ HIV This Week contains a brief on the Scientific Strategic Plan of the Enterprise. The editors note that “a quick read of this forward-looking framework will help you better understand the...

According to a single-patient study published in the October issue of Nature Communications, B-cells and neutralizing antibodies might control HIV levels better than scientists previously suspected. The authors of the study note that the finding...

Los Alamos National Laboratory announced that one of its researchers, Bette Korber, is part of an international team of investigators working to design and implement the first human trial of a mosaic HIV vaccine candidate.  The team is led...

In an article in Global Health, Seth Berkley of IAVI discussed the role of recent scientific breakthroughs in the elicitation of sufficiently potent antibodies against many of the subtypes of HIV in circulation. According to Berkley, the recent...

AIDS Vaccine 2010 - October 08, 2010

More than 1,100 individuals from around the world attended AIDS Vaccine 2010 (28 September - 1 October) in Atlanta, Georgia. Information on the meeting, including speaker presentations, webcasts of special sessions and press conferences, photos...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account